This topic contains a solution. Click here to go to the answer

Author Question: A researcher is conducting a small-scale trial run designed to test methods to be used in a larger, ... (Read 151 times)

Marty

  • Hero Member
  • *****
  • Posts: 553
A researcher is conducting a small-scale trial run designed to test methods to be used in a larger, more rigorous study. What type of study is this called?
 
  A) Panel
  B) Feasibility
  C) Trend
  D) Cohort

Question 2

A common pitfall in intervention research is for intervention agents who offer intervention to control group members and contaminate the research design. What is one common cause and contributor to this pitfall?
 
  A) Low salience of problem
  B) Misgivings about the intervention or about research more generally
  C) Inadequate incentive to cooperate in the research design
  D) Inability to forget intervention protocols when caring for nonintervention patients



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Danny Ewald

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

B

Answer to Question 2

D




Marty

  • Member
  • Posts: 553
Reply 2 on: Jul 8, 2018
Excellent


raili21

  • Member
  • Posts: 324
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

If all the neurons in the human body were lined up, they would stretch more than 600 miles.

Did you know?

A strange skin disease referred to as Morgellons has occurred in the southern United States and in California. Symptoms include slowly healing sores, joint pain, persistent fatigue, and a sensation of things crawling through the skin. Another symptom is strange-looking, threadlike extrusions coming out of the skin.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library